NCT00483041 - A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

June 30, 2009

Conditions

Asthma

Interventions

OTHER

PLACEBO

Placebo administered as a single intravenous infusion

BIOLOGICAL

MEDI528 9 mg/kg

MEDI-528 at a dose of 9 mg/kg administered as a single intravenous infusion

Trial Locations (4)

Wake Forest University, Baptist Medicial Center, Winston-Salem

University of Wisconsin, Section of Allergy, Pulmonary & Critical Care, Madison

Washington Univeristy School of Medicine, Division of Pulmonary and Critical Care Medicine, St Louis

Brigham & Women's Hospital Asthma Research, Boston